T-cell acute lymphoblastic leukemia (T-ALL) is an immature hematopoietic malignancy driven mainly by oncogenic activation of NOTCH1 signaling. In this study we chemically inhibited the deubiquinating enzyme USP7 and assayed for gene expression changes. This piece of data was further integrated to epigenetic changes using ChIP-Sequencing analysis of H3K27me3, H2AUb, H2BUb, H3K27Ac and H3K79me2 upon inhibition of USP7. These results coupled helped to determine the role of USP7 in stabilizing and promoting T-ALL leukemia. We also compared the gene expression and epigenetic changes of USP7 inhibition with inhibition of NOTCH1 pathway and JMJD3. SOURCE: Panagiotis Ntziachristos (panos.ntz@northwestern.edu) - Searle Building Room 6-523 Northwestern University

Pluto Bioinformatics

GSE97435: USP7 controls the oncogenic transcriptional circuitry and is a novel therapeutic target in T cell leukemia